Pontocerebellar Hypoplasia Type 9
Description
Pontocerebellar hypoplasia type 9 is a rare, genetic, subtype of non-syndromic pontocerebellar hypoplasia characterized by progressive cerebellum and brainstem atrophy, corpus callosum hypo-/aplasia and progressive post-natal microcephaly. Patients typically present profound global developmental delay, spastic tetraparesis, seizures, cortical visual impairment and, on neuroimaging, abnormal brain morphology that includes pontocerebellar hypoplasia, ''figure of 8'' midbrain appearance, and, more variably, interhemispheric cysts, ventriculomegaly and cerebral dysmyelination.
Clinical Features
Top most frequent phenotypes and symptoms related to Pontocerebellar Hypoplasia Type 9
- Seizures
- Global developmental delay
- Generalized hypotonia
- Microcephaly
- Spasticity
- Visual impairment
- Peripheral neuropathy
- Hyperreflexia
- Wide nasal bridge
- Optic atrophy
And another 26 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Pontocerebellar Hypoplasia Type 9 Is also known as pch9.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Pontocerebellar Hypoplasia Type 9 Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
Cerebellar/Pontocerebellar Hypoplasia Sequencing Panel.
By Genetic Services Laboratory University of Chicago (United States).
TUBA8, VLDLR, VRK1, CASK, TSEN34, CDK5, EXOSC3, TUBA1A, TUBB3, RARS2, TSEN54, TSEN2, SEPSECS, TUBB2B, AMPD2, OPHN1, CHMP1A, RELN
Specificity
6 %
Genes
100 % |
Cerebellar/Pontocerebellar Hypoplasia Deletion/Duplication Panel.
By Genetic Services Laboratory University of Chicago (United States).
TUBA8, VLDLR, VRK1, CASK, TSEN34, CDK5, EXOSC3, TUBA1A, TUBB3, RARS2, TSEN54, TSEN2, SEPSECS, TUBB2B, AMPD2, OPHN1, CHMP1A, RELN
Specificity
6 %
Genes
100 % |
Hereditary spastic paraplegia AR, X-linked (NGS panel for 33 genes).
By CGC Genetics (Portugal).
SPG11, SPG7, TFG, ERLIN2, PNPLA6, GJC2, SPART, GBA2, DDHD1, TECPR2, SPG21, CYP2U1, ZFYVE26, FA2H, AP5Z1, VPS37A, C19orf12, CYP7B1, C12orf65, DDHD2 , (...)
View the complete list with 13 more genes
Specificity
4 %
Genes
100 % |
Microcephaly and pontocerebellar hypoplasia (NGS panel for 52 genes).
By CGC Genetics (Portugal).
STIL, BUB1B, TUBG1, VRK1, SLC25A19, NIN, CASK, TSEN34, ZNF335, PCNT, STAMBP, CLP1, CENPJ, NDE1, EXOSC3, TUBGCP6, IER3IP1, CDK5RAP2, ASPM, MBD5 , (...)
View the complete list with 32 more genes
Specificity
2 %
Genes
100 % |
Hereditary spastic paraplegia (NGS panel for 43 genes).
By CGC Genetics (Portugal).
RTN2, SPG11, ATL1, SPAST, SPG7, TFG, ERLIN2, BSCL2, PNPLA6, NIPA1, GJC2, SPART, GBA2, DDHD1, TECPR2, SPG21, CYP2U1, ZFYVE26, FA2H, AP5Z1 , (...)
View the complete list with 23 more genes
Specificity
3 %
Genes
100 % |
Pontocerebellar hypoplasia type 9 (sequence analysis of AMPD2 gene).
By CGC Genetics (Portugal).
AMPD2
Specificity
100 %
Genes
100 % |
Pontocerebellar hypoplasia type 9 (sequence analysis of AMPD2 gene).
By CGC Genetics (Portugal).
AMPD2
Specificity
100 %
Genes
100 % |
Complex Hereditary Spastic Paraplegia Sequencing Panel with CNV Detection.
By PreventionGenetics PreventionGenetics (United States).
SACS, SLC16A2, KDM5C, SPG11, ATL1, SPAST, SPG7, TFG, UCHL1, USP8, VCP, ERLIN2, CAPN1, BSCL2, CCT5, PNPLA6, NIPA1, RAB3GAP2, BICD2, GJC2 , (...)
View the complete list with 50 more genes
Specificity
2 %
Genes
100 % |
You can get up to 14 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
OMIM ORPHANET Genetic Syndrome FinderIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like VENTRICULAR SEPTAL DEFECT 2; VSD2 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1 SPERMATOGENIC FAILURE 6; SPGF6 WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS